作者：董敖渤drugprevention
摘要：Objective To explore HIV-1 drug resistance and influencing factors among people living with HIV/AIDS before antiretroviral therapy in Liangshan Yi Autonomous Prefecture(Liangshan).Methods Between January 1 and June 30,in both 2017 and 2018,a cross-sectional survey was conducted in Liangshan,HIV-1 pol sequences were gathered and analyzed according to WHO Guidelines on HIV drug resistance surveillance of 2014.Both HyPhy 2.2.4 and Cytoscape 3.6.1 software were used to analyze the drug resistant strains of HIV-1 transmission network.Results A total of 464 people living with HIV/AIDS was recruited.The proportion of HIV-1 CRF07_BC subtype was 88.6%(411/464),with HIV-1 drug resistance rate was 9.9%(46/464).The HIV-1 drug resistance rates of non-nucleoside reverse transcriptase inhibitors(NNRTI),nucleoside reverse transcriptase inhibitors(NRTI)and protease inhibitors(PI)were 6.7%(31/464),1.9%(9/464)and 0.4%(2/464)respectively.New recombinant strains of HIV-1 URF_01BC subtype was independently clustered according to the drug resistant mutation sites.Results from the multivariate logistic analysis showed that injected drug users group had higher risk on HIV-1 drug resistance(aOR=3.03,95%CI:1.40-6.54)than heterosexual group among people living with HIV/AIDS.Conclusion HIV-1 drug resistance rate had already been in a high level before antiretroviral therapy was in place.The newly identified recombinant strains of HIV-1 URF_01BC subtype were independently clustered according to the drug resistant mutation sites.It was necessary to strengthen the prevention of the HIV-1 drug resistant strains transmission.
注：因版权方要求，不能公开全文，如需全文，请咨询杂志社
